RE: NEWS RELEASENice to finnaly not have a PP news release. As for this news it was something known if you looked at the company website and their presentation to investors. This test should be with the more stable compound developed at the new lab that Dr. Sokoll choose. Formula wise it is the same thing but he wanted more consistency in how the drug was produced. If you wanted to know the effectiveness in Bladder you can look back at the NCI results last year and see their effectiveness in the two tests they did. Now since this is the mention of the collaboration it is hard to say if things have already been in progress or the testing will begin next semester. Also results will be a slow process cause they will have to measure the cell death or inhibition. So before you invest make sure you are willing to stay long term cause the past results have shown they do take time and patience is a virtue here.